Paper22956830
Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Sträussler-Scheinker disease.
Cortes CJ and 4 others. J Neurosci, 2012. Cited by 88 papers, by iCite.
Cite this record
ConductScience Library. Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Sträussler-Scheinker disease. Papers, record 22956830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22956830
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Disease Models, Animal | Major topic |
| Gerstmann-Straussler-Scheinker Disease | Major topic |
| Plaque, Amyloid | Major topic |
| Prions | Major topic |
| Sirolimus | Major topic |
| Animals | |
| Female | |
| Male | |
| Mice | |
| Mice, Knockout | |
| Mice, Transgenic | |
| Random Allocation | |
| Time Factors |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 NS051480 | NINDS NIH HHS | United States | R01NS051480 | PubMed and NIH |
| R01NS051480 | NINDS NIH HHS | United States | R01NS051480 | PubMed and NIH |
Source NIH RePORTER
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17330103 | The anticancer drug imatinib induces cellular autophagy. | Leukemia | 2007 | https://conductscience.org/library/papers/17330103 | PubMed |
| 2 | 18199701 | Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis. | Mol Pharmacol | 2008 | https://conductscience.org/library/papers/18199701 | PubMed |
| 3 | 11522774 | Prion protein protects human neurons against Bax-mediated apoptosis. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11522774 | PubMed |
| 4 | 17118264 | Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. | Curr Top Dev Biol | 2006 | https://conductscience.org/library/papers/17118264 | PubMed |
| 5 | 12917444 | Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12917444 | PubMed |
| 6 | 9811807 | Prions. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9811807 | PubMed |
| 7 | 16226444 | Growing roles for the mTOR pathway. | Curr Opin Cell Biol | 2005 | https://conductscience.org/library/papers/16226444 | PubMed |
| 8 | 19767652 | Autophagy, prion infection and their mutual interactions. | Curr Issues Mol Biol | 2010 | https://conductscience.org/library/papers/19767652 | PubMed |
| 9 | 16368705 | Rapamycin alleviates toxicity of different aggregate-prone proteins. | Hum Mol Genet | 2006 | https://conductscience.org/library/papers/16368705 | PubMed |
| 10 | 12878853 | Rapamycins: mechanism of action and cellular resistance. | Cancer Biol Ther | 2003 | https://conductscience.org/library/papers/12878853 | PubMed |
| 11 | 11978769 | Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. | Hum Mol Genet | 2002 | https://conductscience.org/library/papers/11978769 | PubMed |
| 12 | 17182613 | Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17182613 | PubMed |
| 13 | 18250315 | Lithium delays progression of amyotrophic lateral sclerosis. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18250315 | PubMed |
| 14 | 17331981 | Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II). | Hum Mol Genet | 2007 | https://conductscience.org/library/papers/17331981 | PubMed |
| 15 | 17849316 | The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery. | J Neurovirol | 2007 | https://conductscience.org/library/papers/17849316 | PubMed |
| 16 | 11052993 | Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. | Am J Physiol Gastrointest Liver Physiol | 2000 | https://conductscience.org/library/papers/11052993 | PubMed |
| 17 | 19675240 | A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP. | J Neurosci | 2009 | https://conductscience.org/library/papers/19675240 | PubMed |
| 18 | 20376313 | Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. | PLoS One | 2010 | https://conductscience.org/library/papers/20376313 | PubMed |
| 19 | 20190788 | Protein aggregation diseases: pathogenicity and therapeutic perspectives. | Nat Rev Drug Discov | 2010 | https://conductscience.org/library/papers/20190788 | PubMed |
| 20 | 20174468 | Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. | PLoS One | 2010 | https://conductscience.org/library/papers/20174468 | PubMed |
Cited by61
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42008486 | Prion propagation is controlled by a hierarchical network involving the nuclear Tfap2c and hnRNP K factors and the cytosolic mTORC1 complex. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42008486 | PubMed |
| 41004055 | Therapeutic Trajectories in Human Prion Diseases. | Subcell Biochem | 2025 | https://conductscience.org/library/papers/41004055 | PubMed |
| 41004053 | New Therapeutic Modalities in Prion Diseases. | Subcell Biochem | 2025 | https://conductscience.org/library/papers/41004053 | PubMed |
| 40956390 | Retinitis Pigmentosa-Associated Gene TRIM49 Regulates ULK1-Mediated Autophagy and Photoreceptor Phagocytosis by the Retinal Pigment Epithelium. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40956390 | PubMed |
| 40781739 | Contrasting roles of autophagy in cellular prion infection. | Autophagy | 2025 | https://conductscience.org/library/papers/40781739 | PubMed |
| 40708570 | Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024). | Explor Drug Sci | 2025 | https://conductscience.org/library/papers/40708570 | PubMed |
| 40532025 | Microglia-specific NF-κB signaling is a critical regulator of prion-induced glial inflammation and neuronal loss. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40532025 | PubMed |
| 40342093 | Autophagy in cancer and protein conformational disorders. | FEBS Lett | 2025 | https://conductscience.org/library/papers/40342093 | PubMed |
| 38557815 | Anti-prion drugs do not improve survival in novel knock-in models of inherited prion disease. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/38557815 | PubMed |
| 37142830 | Targeting the biology of aging with mTOR inhibitors. | Nat Aging | 2023 | https://conductscience.org/library/papers/37142830 | PubMed |
| 36984858 | Neurodegeneration, Mitochondria, and Antibiotics. | Metabolites | 2023 | https://conductscience.org/library/papers/36984858 | PubMed |
| 36558997 | FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/36558997 | PubMed |
| 36148145 | Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets. | Front Neurosci | 2022 | https://conductscience.org/library/papers/36148145 | PubMed |
| 35676449 | Brain aging is faithfully modelled in organotypic brain slices and accelerated by prions. | Commun Biol | 2022 | https://conductscience.org/library/papers/35676449 | PubMed |
| 34461258 | SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling. | Biochim Biophys Acta Mol Basis Dis | 2021 | https://conductscience.org/library/papers/34461258 | PubMed |
| 34209482 | MicroRNAs in Prion Diseases-From Molecular Mechanisms to Insights in Translational Medicine. | Cells | 2021 | https://conductscience.org/library/papers/34209482 | PubMed |
| 33117143 | Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease. | Front Aging Neurosci | 2020 | https://conductscience.org/library/papers/33117143 | PubMed |
| 33092231 | A New Take on Prion Protein Dynamics in Cellular Trafficking. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33092231 | PubMed |
| 32984276 | An Update on Autophagy in Prion Diseases. | Front Bioeng Biotechnol | 2020 | https://conductscience.org/library/papers/32984276 | PubMed |
| 32937909 | Activate or Inhibit? Implications of Autophagy Modulation as a Therapeutic Strategy for Alzheimer's Disease. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32937909 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22956830
GET https://conductscience.org/api/papers/v1/22956830/references?page=2